Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Leiomyoma 7 Cushing Syndrome 4 ACTH Syndrome, Ectopic 4 Prostatic Neoplasms 3 Pituitary Diseases 3 Pituitary ACTH Hypersecretion 3 Triple Negative Breast Neoplasms 2 Ovarian Neoplasms 2 Hirsutism 2 Fallopian Tube Neoplasms 2 Choristoma 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Adrenal Cortex Neoplasms 2 Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 1 Uterine Hemorrhage 1 Sarcoma 1 Neoplasms 1 Meningioma 1 Gulf War Illness 1 Endometrial Stromal Tumors 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Cancer Female 1

Interventions

Magnetic Resonance Spectroscopy 16 Hydroxyurea 7 Everolimus 7 Bevacizumab 7 lutetium Lu 177 dotatate 6 gallium Ga 68 dotatate 6 Proton Therapy 6 Specimen Handling 5 pembrolizumab 4 Surgical Procedures, Operative 4 Radiosurgery 4 Imatinib Mesylate 4 Cyclophosphamide 4 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4 aldesleukin 3 abemaciclib 3 Tranexamic Acid 3 Temozolomide 3 Sunitinib 3 Sodium Chloride 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Nivolumab 3 Ga(III)-DOTATOC 3 90Y-octreotide, DOTA-Tyr(3)- 3 vistusertib 2 trametinib 2 ribociclib 2 fludarabine 2 arginyllysine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Meningioma × Mifepristone × Clear all

NCT03015701 2019-12-23

S9005 Mifepristone in Meningioma

SWOG Cancer Research Network

Phase 3 Completed

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡